MPX – Trademark Portfolio

Entity Type: 03

MPX holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 10 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. Currently, 9 trademarks are registered and 1 is pending. Notable registered marks include MPX, GOVLINQ, MPXLINQ, ENERGYLINQ, and HEALTHLINQ. The owner is based in Portland, ME.

2301 Congress Street

Portland, ME 04102

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MPX's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (10 filings)

Scientific and technological services; industrial analysis and research services

40
Treatment & Processing (10 filings)

Treatment of materials

35
Advertising & Business (9 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does MPX have?

MPX has 10 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 pending.

What trademark classes does MPX file in?

MPX files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.

What are MPX's most well-known trademarks?

MPX's registered trademark portfolio includes well-known marks such as MPX, GOVLINQ, MPXLINQ, ENERGYLINQ, and HEALTHLINQ. These are among 9 currently registered trademarks in the portfolio.

What is MPX's trademark registration success rate?

MPX has a 100% trademark registration rate, with 9 out of 9 resolved applications resulting in successful registration. Currently, 1 application is pending review.